文献速递腹部技术与安全CT

光子计数探测器CT用于肝脏病灶检测:不同模拟患者体型与辐射剂量下的最佳虚拟单能能量

Photon-Counting Detector CT for Liver Lesion Detection-Optimal Virtual Monoenergetic Energy for Different Simulated Patient Sizes and Radiation Doses.
PubMed 文献 · Invest Radiol · 2024-01-03

研究用模拟腹部体模在双源光子计数探测器CT上成像,评估不同体型与辐射剂量下虚拟单能图像检测肝病灶的最佳能量。结果示中、大体模中低强化与高强化病灶均在65和70 keV获得最高可检测性,与剂量无关;40 keV最低,剂量降低时40-50 keV可检测性下降比65-75 keV更明显。

要点

  • 中、大体模中肝脏低强化与高强化病灶在65和70 keV虚拟单能图像上可检测性最高,与辐射剂量无关。
  • 40 keV时不论剂量与体模大小可检测性均最低,AUC范围0.78-0.99。
  • 降低辐射剂量时,40-50 keV较65-75 keV的可检测性下降更明显。

核心结论

  • 不同体模大小与辐射剂量下,虚拟单能图像检测低强化和高强化肝病灶的可检测性随能量不同而异,65和70 keV在独立于体模大小和辐射剂量时获得最高可检测性。

研究设计与样本

  • 体模研究:在双源光子计数探测器CT(120 kVp)上对含肝实质和病灶的腹部体模成像,5个低强化病灶(病灶-背景对比差-30 HU和-45 HU)和3个高强化病灶(+30 HU和+90 HU),病灶直径5-10 mm;加脂肪等效环模拟中、大体型患者,中体模在容积CT剂量指数5、2.5、1.25 mGy下成像,大体模在5和2.5 mGy下成像,每种设置成像10次。

关键影像表现/征象

  • 低强化和高强化肝病灶均为低衰减/高衰减病灶,病灶-背景对比差分别为-30 HU、-45 HU和+30 HU、+90 HU,直径5-10 mm。
  • 虚拟单能图像从40到80 keV以5 keV递增重建,采用量子迭代重建强度4(QIR-4)。
  • 中体模AUC范围0.91-1.0,大体模AUC范围0.94-0.99,最高可检测性均在65和70 keV。
  • 40 keV时AUC范围0.78-0.99,为最低可检测性。

诊断标准与关键数值

  • 可检测性以受试者工作特征曲线下面积(AUC)衡量,采用带10个密集高斯差分通道的通道化Hotelling模型观察者。
  • 中体模在65和70 keV最高可检测性AUC范围0.91-1.0,大体模AUC范围0.94-0.99,均独立于辐射剂量。
  • 40 keV时不论辐射剂量和体模大小AUC范围0.78-0.99,为最低。
  • 降低辐射剂量时,40-50 keV较65-75 keV的可检测性下降更明显。
  • 相同辐射剂量下,可检测性随虚拟单能能量变化在大体模比中体模更明显(12% vs 6%)。

临床应用与阅片要点

  • 对于光子计数探测器CT肝脏病灶检测,65和70 keV虚拟单能图像在不同体模大小和辐射剂量下均显示最高可检测性。
  • 40 keV虚拟单能图像可检测性最低,降低辐射剂量时40-50 keV可检测性下降较65-75 keV更明显。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The aim of this study was to evaluate the optimal energy level of virtual monoenergetic images (VMIs) from photon-counting detector computed tomography (CT) for the detection of liver lesions as a function of phantom size and radiation dose.

MATERIALS AND METHODS: An anthropomorphic abdominal phantom with liver parenchyma and lesions was imaged on a dual-source photon-counting detector CT at 120 kVp. Five hypoattenuating lesions with a lesion-to-background contrast difference of -30 HU and -45 HU and 3 hyperattenuating lesions with +30 HU and +90 HU were used. The lesion diameter was 5-10 mm. Rings of fat-equivalent material were added to emulate medium- or large-sized patients. The medium size was imaged at a volume CT dose index of 5, 2.5, and 1.25 mGy and the large size at 5 and 2.5 mGy, respectively. Each setup was imaged 10 times. For each setup, VMIs from 40 to 80 keV at 5 keV increments were reconstructed with quantum iterative reconstruction at a strength level of 4 (QIR-4). Lesion detectability was measured as area under the receiver operating curve (AUC) using a channelized Hotelling model observer with 10 dense differences of Gaussian channels.

RESULTS: Overall, highest detectability was found at 65 and 70 keV for both hypoattenuating and hyperattenuating lesions in the medium and large phantom independent of radiation dose (AUC range, 0.91-1.0 for the medium and 0.94-0.99 for the large phantom, respectively). The lowest detectability was found at 40 keV irrespective of the radiation dose and phantom size (AUC range, 0.78-0.99). A more pronounced reduction in detectability was apparent at 40-50 keV as compared with 65-75 keV when radiation dose was decreased. At equal radiation dose, detection as a function of VMI energy differed stronger for the large size as compared with the medium-sized phantom (12% vs 6%).

CONCLUSIONS: Detectability of hypoattenuating and hyperattenuating liver lesions differed between VMI energies for different phantom sizes and radiation doses. Virtual monoenergetic images at 65 and 70 keV yielded highest detectability independent of phantom size and radiation dose.

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Racine D, Mergen V, Viry A, et al. Photon-Counting Detector CT for Liver Lesion Detection-Optimal Virtual Monoenergetic Energy for Different Simulated Patient Sizes and Radiation Doses. Invest Radiol. 2024. PMID: 38193782. doi:10.1097/RLI.0000000000001060

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。